Brilinta 60 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FTWP5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,748
Award facts
- Contract value 100% obligated
- $1,748.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Brilinta 60 mg tablets valued at $1,748.44. The contract, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group will perform this delivery from its location in Conshohocken, Pennsylvania. This award is issued under the company's existing Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, a $499.999 billion contract vehicle that enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs of military health facilities worldwide.
As a established federal pharmaceutical supplier since 2001, DMS Pharmaceutical Group maintains a robust portfolio of delivery orders covering prescription medications, biologics, and medical consumables distributed to Department of Defense healthcare facilities. Brilinta is a cardiovascular medication, and this particular delivery order contributes to the company's ongoing role as a critical supplier in the federal pharmaceutical supply chain. The firm fixed-price structure and rapid completion timeline reflect the operational efficiency required to support military healthcare logistics, with the delivery order fulfilling immediate pharmaceutical needs within the Defense Logistics Agency's medical supply network.
Quick answers
Who was awarded contract SPE2DB25FTWP5?
SPE2DB25FTWP5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FTWP5 worth?
The government has obligated $1,748 on SPE2DB25FTWP5.
Is contract SPE2DB25FTWP5 an order under another contract?
Yes. SPE2DB25FTWP5 is a delivery order under SPE2DB20D6037, an indefinite delivery contract.
Was contract SPE2DB25FTWP5 competed?
The extent of competition for SPE2DB25FTWP5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award